\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ unremarkable\\ except\\ mild\\ diffuse\\ abdominal\\ tenderness\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ 11\\.1\\	\\	mcv\\ 65\\ \\	fe\\ 5\ \(0\)\
\-\ 7\\.7\\ \\>\\-\\-\\-\\-\\-\\-\\-\\-\\<\\ 421\\	rdw\\ 21\\ \\	tibc\\ 289\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ 34\\.7\\	\\	retic\\ 1\\.8\\%\\	fe\\ sat\\ 1\\.7\\%\ \(0\)\
\-\ esr\\ 54\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ bmp\\ wnl\ \(0\)\
\-\ a\\ colonoscopy\\ was\\ done\\ prior\\ to\\ ct\\ and\\ pt\\ was\\ subsequently\\ dxed\\ with\\ fap\\ \\(familial\\ adenomatous\\ polyposis\\)\\.\\ \\ pt\\ was\\ then\\ transferred\\ for\\ prophylactic\\ proctocolectomy\\.\\ performed\\ ln\\ bx\\ without\\ proctocolectomy\\.\\ \\ want\\ to\\ tx\\ ca\\ that\\ patient\\ has\\ now\\ and\\ worry\\ about\\ ca\\ that\\ he\\ will\\ get\\ after\\ resolution\\ of\\ current\\ problem\\.\\ pt\\ was\\ transferred\\ to\\ texas\\ for\\ tx\\ and\\ f\\/u\\ in\\ order\\ to\\ be\\ near\\ family\ \(0\)\
\-\ ct\\ abdomen\\/pelvis\\:\\ \\	\ \(0\)\
\-\ 1\\.\\ 1\\ cm\\ lll\\ lobulated\\ nodule\\ \\	\ \(0\)\
\-\ 2\\.\\ 8\\ mm\\ enhancing\\ right\\ hepatic\\ lobe\\ lesion\\ \\	\ \(1\)\
\-\ 3\\.\\ questionable\\ 2\\.5\\ cm\\ soft\\ tissue\\ density\\ in\\ cecum\\ which\\ appears\\ contiguous\\ with\\ wall\\ \\	\ \(0\)\
\-\ 4\\.\\ multiple\\ enlarged\\ ln\\ in\\ right\\ common\\ iliac\\ chain\\ and\\ extending\\ to\\ right\\ common\\ femoral\\ chain\ \(0\)\
\-\ hodgkin\\â\\€\\™s\\ lymphoma\\ \\(nodular\\ lymphocytic\\ predominant\\)\ \(0\)\
\-\ 1\\.\\ infection\\,\\ inflammation\\,\\ malignancy\ \(0\)\
\-\ 2\\.\\ likely\\ benign\\ mass\\;\\ hemangioma\\ vs\\.\\ adenoma\\,\\ may\\ be\\ metastatic\\ disease\ \(0\)\
\-\ 3\\.\\ polyp\\,\\ ca\\,\\ feces\ \(0\)\
\-\ 4\\.\\ lymphoma\\ vs\\.\\ metastatic\\ disease\ \(0\)\
\-\ 19\\ yo\\ wm\\ with\\ h\\/o\\ fatigue\\ and\\ exercise\\ intolerance\\ during\\ basic\\ training\\.\\ \\ w\\/u\\ revealed\\ microcytic\\ anemia\\ with\\ heme\\ positive\\ stool\\.\\ pt\\ was\\ otherwise\\ healthy\\ with\\ no\\ significant\\ pmhx\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ proctocolectomy\\:\\ 0\\.0769914272835502\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.06856190909597806\ \(0\)\
\-\ ln\\:\\ 0\\.06739656013361038\ \(0\)\
\-\ fe\\:\\ 0\\.0648840529506254\ \(0\)\
\-\ pt\\:\\ 0\\.05549631012458956\ \(0\)\
\-\ ca\\:\\ 0\\.052129736030764456\ \(0\)\
\-\ chain\\:\\ 0\\.050401711670245194\ \(0\)\
\-\ tx\\:\\ 0\\.04619351877161866\ \(0\)\
\-\ transferred\\:\\ 0\\.04013983160515625\ \(0\)\
\-\ 289\\:\\ 0\\.0384957136417751\ \(0\)\
\-\ retic\\:\\ 0\\.0384957136417751\ \(0\)\
\-\ dxed\\:\\ 0\\.0384957136417751\ \(0\)\
\-\ fap\\:\\ 0\\.0384957136417751\ \(0\)\
\-\ 421\\:\\ 0\\.0354688700585439\ \(0\)\
\-\ 34\\.7\\:\\ 0\\.0354688700585439\ \(0\)\
\-\ texas\\:\\ 0\\.0354688700585439\ \(0\)\
\-\ microcytic\\:\\ 0\\.03369828006680519\ \(0\)\
\-\ heme\\:\\ 0\\.0324420264753127\ \(0\)\
\-\ tibc\\:\\ 0\\.03146760048704104\ \(0\)\
\-\ worry\\:\\ 0\\.03146760048704104\ \(0\)\
\-\ feces\\:\\ 0\\.03146760048704104\ \(0\)\
\-\ w\\/u\\:\\ 0\\.03146760048704104\ \(0\)\
\-\ 11\\.1\\:\\ 0\\.030671436483573986\ \(0\)\
\-\ want\\:\\ 0\\.02999828941009251\ \(0\)\
\-\ 4\\.\\:\\ 0\\.02938410454498513\ \(0\)\
\-\ vs\\:\\ 0\\.02938410454498513\ \(0\)\
\-\ bx\\:\\ 0\\.028900846491835275\ \(0\)\
\-\ 7\\.7\\:\\ 0\\.028440756903809834\ \(0\)\
\-\ polyposis\\:\\ 0\\.028440756903809834\ \(0\)\
\-\ rdw\\:\\ 0\\.027295061425785853\ \(0\)\
\-\ lll\\:\\ 0\\.02638833930885029\ \(0\)\
\-\ 3\\.\\:\\ 0\\.02553601932000635\ \(0\)\
\-\ mcv\\:\\ 0\\.025200855835122597\ \(0\)\
\-\ adenomatous\\:\\ 0\\.024997711662044463\ \(0\)\
\-\ bmp\\:\\ 0\\.02461774931711158\ \(0\)\
\-\ abdomen\\/pelvis\\:\\ 0\\.02461774931711158\ \(0\)\
\-\ predominant\\:\\ 0\\.024103412916865366\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.023944602243630105\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.023791365039214075\ \(0\)\
\-\ basic\\:\\ 0\\.023791365039214075\ \(0\)\
\-\ training\\:\\ 0\\.023791365039214075\ \(0\)\
\-\ wm\\:\\ 0\\.02364332332883992\ \(0\)\
\-\ 1\\.7\\:\\ 0\\.02350013632961289\ \(0\)\
\-\ f\\/u\\:\\ 0\\.023227121670305752\ \(0\)\
\-\ hodgkin\\:\\ 0\\.023227121670305752\ \(0\)\
\-\ intolerance\\:\\ 0\\.023227121670305752\ \(0\)\
\-\ prophylactic\\:\\ 0\\.022970176255358445\ \(0\)\
\-\ familial\\:\\ 0\\.022847159325372873\ \(0\)\
\-\ get\\:\\ 0\\.022847159325372873\ \(0\)\
\-\ pmhx\\:\\ 0\\.02207125898809142\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.021776755578503944\ \(0\)\
\-\ was\\:\\ 0\\.021578111838726786\ \(0\)\
\-\ contiguous\\:\\ 0\\.021500865178409916\ \(0\)\
\-\ lymphoma\\:\\ 0\\.021329245715192013\ \(0\)\
\-\ sat\\:\\ 0\\.02124137425932345\ \(0\)\
\-\ polyp\\:\\ 0\\.02124137425932345\ \(0\)\
\-\ cecum\\:\\ 0\\.021158194368621732\ \(0\)\
\-\ questionable\\:\\ 0\\.021076569333634165\ \(0\)\
\-\ stool\\:\\ 0\\.020544299387743173\ \(0\)\
\-\ problem\\:\\ 0\\.02040342226015269\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.02020027808707455\ \(0\)\
\-\ cm\\:\\ 0\\.020017083998401623\ \(0\)\
\-\ fatigue\\:\\ 0\\.019943332672127244\ \(0\)\
\-\ 54\\:\\ 0\\.01970066956664772\ \(0\)\
\-\ common\\:\\ 0\\.01953071800835281\ \(0\)\
\-\ h\\/o\\:\\ 0\\.019470784267584744\ \(0\)\
\-\ wnl\\:\\ 0\\.019147168668660192\ \(0\)\
\-\ exercise\\:\\ 0\\.019147168668660192\ \(0\)\
\-\ except\\:\\ 0\\.018894681459538685\ \(0\)\
\-\ esr\\:\\ 0\\.018894681459538685\ \(0\)\
\-\ metastatic\\:\\ 0\\.01878698169097022\ \(0\)\
\-\ lobulated\\:\\ 0\\.01874991199527274\ \(0\)\
\-\ order\\:\\ 0\\.018702702754642978\ \(0\)\
\-\ iliac\\:\\ 0\\.018609788350943044\ \(0\)\
\-\ anemia\\:\\ 0\\.01856406215064918\ \(0\)\
\-\ 65\\:\\ 0\\.01821453067609225\ \(0\)\
\-\ 1\\:\\ 0\\.01775830889047779\ \(0\)\
\-\ current\\:\\ 0\\.017481808159799477\ \(0\)\
\-\ \\%\\:\\ 0\\.01740891732179919\ \(0\)\
\-\ 19\\:\\ 0\\.017206642361420728\ \(0\)\
\-\ subsequently\\:\\ 0\\.016916489088896043\ \(0\)\
\-\ 21\\:\\ 0\\.01688540844361716\ \(0\)\
\-\ healthy\\:\\ 0\\.01682390302928642\ \(0\)\
\-\ pe\\:\\ 0\\.016763251884480017\ \(0\)\
\-\ hemangioma\\:\\ 0\\.016673825983416518\ \(0\)\
\-\ near\\:\\ 0\\.016146395683623332\ \(0\)\
\-\ resolution\\:\\ 0\\.016094409209796615\ \(0\)\
\-\ inflammation\\:\\ 0\\.01586783787630748\ \(0\)\
\-\ nodular\\:\\ 0\\.015652444572541096\ \(0\)\
\-\ hepatic\\:\\ 0\\.015582944767711843\ \(0\)\
\-\ adenoma\\:\\ 0\\.015582944767711843\ \(0\)\
\-\ done\\:\\ 0\\.015469514696081883\ \(0\)\
\-\ nodule\\:\\ 0\\.015380845411537144\ \(0\)\
\-\ family\\:\\ 0\\.015293940807531487\ \(0\)\
\-\ malignancy\\:\\ 0\\.014419605579919283\ \(0\)\
\-\ \\<\\:\\ 0\\.014402032871186857\ \(0\)\
\-\ about\\:\\ 0\\.01438453059434171\ \(0\)\
\-\ femoral\\:\\ 0\\.014196497889274256\ \(0\)\
\-\ 8\\:\\ 0\\.01395247842030283\ \(0\)\
\-\ appears\\:\\ 0\\.01388964550566484\ \(0\)\
\-\ mm\\:\\ 0\\.013721376230545874\ \(0\)\
\-\ otherwise\\:\\ 0\\.013403123290071374\ \(0\)\
\-\ then\\:\\ 0\\.013279331346821351\ \(0\)\
\-\ that\\:\\ 0\\.012890661384793216\ \(0\)\
\-\ benign\\:\\ 0\\.012877949201018346\ \(0\)\
\-\ now\\:\\ 0\\.01275596327380632\ \(0\)\
\-\ enlarged\\:\\ 0\\.012731969739668149\ \(0\)\
\-\ extending\\:\\ 0\\.012544624667422694\ \(0\)\
\-\ \\>\\:\\ 0\\.012398111417766656\ \(0\)\
\-\ unremarkable\\:\\ 0\\.012354001828305941\ \(0\)\
\-\ density\\:\\ 0\\.012277866187161392\ \(0\)\
\-\ disease\\:\\ 0\\.012198581145988681\ \(0\)\
\-\ positive\\:\\ 0\\.01210867069993064\ \(0\)\
\-\ revealed\\:\\ 0\\.011975868514699096\ \(0\)\
\-\ 2\\.\\:\\ 0\\.01186656830480462\ \(0\)\
\-\ right\\:\\ 0\\.011811769114983625\ \(0\)\
\-\ enhancing\\:\\ 0\\.011702853855391961\ \(0\)\
\-\ will\\:\\ 0\\.011674589599908917\ \(0\)\
\-\ 1\\.\\:\\ 0\\.011655847887762449\ \(0\)\
\-\ be\\:\\ 0\\.0115087923436151\ \(0\)\
\-\ during\\:\\ 0\\.01141925436647951\ \(0\)\
\-\ tenderness\\:\\ 0\\.01134896210865342\ \(0\)\
\-\ diffuse\\:\\ 0\\.011296975634826702\ \(0\)\
\-\ yo\\:\\ 0\\.011228609272064462\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.011152955194958323\ \(0\)\
\-\ 5\\:\\ 0\\.010917731102376258\ \(0\)\
\-\ infection\\:\\ 0\\.010847233947916188\ \(0\)\
\-\ wall\\:\\ 0\\.010808555110212864\ \(0\)\
\-\ s\\:\\ 0\\.010702042214474178\ \(0\)\
\-\ likely\\:\\ 0\\.010525283694042167\ \(0\)\
\-\ ct\\:\\ 0\\.010439333217397755\ \(0\)\
\-\ he\\:\\ 0\\.010411298436825412\ \(0\)\
\-\ performed\\:\\ 0\\.010404272188765584\ \(0\)\
\-\ lobe\\:\\ 0\\.01004072204333421\ \(0\)\
\-\ significant\\:\\ 0\\.01003426703517128\ \(0\)\
\-\ \\:\\:\\ 0\\.009871395772844236\ \(0\)\
\-\ mild\\:\\ 0\\.00982643429664252\ \(0\)\
\-\ prior\\:\\ 0\\.009581278481233028\ \(0\)\
\-\ abdominal\\:\\ 0\\.009327158245074739\ \(0\)\
\-\ to\\:\\ 0\\.00932463118871149\ \(0\)\
\-\ soft\\:\\ 0\\.009087016436653057\ \(0\)\
\-\ tissue\\:\\ 0\\.008844634010710015\ \(0\)\
\-\ \\;\\:\\ 0\\.008844634010710015\ \(0\)\
\-\ without\\:\\ 0\\.008786083695887162\ \(0\)\
\-\ may\\:\\ 0\\.008184840038856436\ \(0\)\
\-\ 2\\:\\ 0\\.008035390814456533\ \(0\)\
\-\ multiple\\:\\ 0\\.007859414862354886\ \(0\)\
\-\ after\\:\\ 0\\.007720529269035818\ \(0\)\
\-\ lesion\\:\\ 0\\.007600677842796745\ \(0\)\
\-\ has\\:\\ 0\\.007007423451940078\ \(0\)\
\-\ which\\:\\ 0\\.006965696887522047\ \(0\)\
\-\ for\\:\\ 0\\.006367756756704935\ \(0\)\
\-\ \\(\\:\\ 0\\.006308836037064284\ \(0\)\
\-\ \\)\\:\\ 0\\.006231770236797424\ \(0\)\
\-\ \\,\\:\\ 0\\.00591070012046479\ \(0\)\
\-\ in\\:\\ 0\\.005520487731095042\ \(0\)\
\-\ mass\\:\\ 0\\.005189786056539583\ \(0\)\
\-\ and\\:\\ 0\\.003930327636074638\ \(0\)\
\-\ no\\:\\ 0\\.003757398038007869\ \(0\)\
\-\ patient\\:\\ 0\\.003740576117538812\ \(0\)\
\-\ with\\:\\ 0\\.0025546763338403873\ \(0\)\
\-\ a\\:\\ 0\\.0017318768638366867\ \(0\)\
\-\ \\.\\:\\ 0\\.0017052178911389042\ \(0\)\
\-\ of\\:\\ 0\\.000508750221825277\ \(0\)\
